The Department of Oncology at Apollo Hospitals, Gurugram, provides assessment and treatment for adults and children with suspected or confirmed cancer, as well as selected blood disorders. Care may involve medical oncology, cancer surgery, radiation oncology, hematology, pediatric oncology, imaging, pathology and supportive care.
Cancer care is planned around the type of cancer, its stage, test results, the person's general health and their priorities. Treatment may include surgery, medicines, radiation therapy, stem cell transplantation or a combination of approaches. Some people also need pain and symptom control, nutrition support, rehabilitation, psychological care or help with the effects of treatment.
Selected or complex cases may be reviewed by specialists from different disciplines so that the diagnosis and treatment options can be considered together. Not every patient needs every test or treatment, and recommendations may change as new information becomes available.
Our Oncology Team
The oncology team may include medical, surgical and radiation oncologists, hematologists, pediatric oncologists, pathologists, radiologists, nuclear medicine physicians, interventional radiologists, oncology nurses, pharmacists, dietitians, rehabilitation professionals, pain specialists and palliative care clinicians. Organ-specific specialists may join the care team when needed. Our specialists include:
- Breast Cancer
- Head, Neck and Thyroid Cancers
- Thoracic Cancers
- Digestive System Cancers
- Gynecologic Cancers
- Genitourinary Cancers
- Blood Cancers and Blood Disorders
- Cancers in Children
- Other Cancers
- Breast cancer: A new breast lump, skin or nipple change, nipple discharge or a lump in the armpit should be assessed. Many breast changes are benign, but examination and imaging help determine whether a biopsy is needed.
- Recurrent or metastatic breast cancer: Cancer that returns or spreads may be managed with systemic treatment, radiation, selected procedures and symptom control. Treatment is guided by previous therapy, disease location and tumor biomarkers.
- Oral and throat cancers: A persistent mouth ulcer, unexplained lump, pain or difficulty swallowing, voice change or neck swelling needs evaluation. Tobacco and areca nut use are important preventable risk factors.
- Laryngeal and salivary gland cancers: Persistent hoarseness, swallowing difficulty, a neck mass or swelling near the jaw may require endoscopy, imaging and biopsy.
- Thyroid cancer: A thyroid nodule is usually not cancer, but selected nodules need ultrasound assessment and needle sampling. Treatment depends on the cancer type, extent and individual risk.
- Lung cancer: Persistent cough, coughing blood, chest pain, unexplained weight loss or breathlessness should be assessed, particularly in people with a smoking or exposure history. Molecular and immune-marker testing is important for many advanced non-small cell lung cancers.
- Pleural and mediastinal tumors: Tumors involving the lining of the lung or central chest may need imaging, tissue diagnosis and coordinated surgical, medical or radiation treatment.
- Esophageal and stomach cancers: Progressive swallowing difficulty, persistent upper abdominal discomfort, vomiting, anemia, bleeding or unexplained weight loss may prompt endoscopy and biopsy.
- Colorectal and anal cancers: A lasting change in bowel habits, rectal bleeding, abdominal pain or iron-deficiency anemia needs assessment. Screening and the removal of precancerous adenomatous polyps can lower colorectal cancer risk.
- Liver, gallbladder, bile duct and pancreatic cancers: Jaundice, dark urine, persistent upper abdominal or back pain, appetite loss or unexplained weight loss may require blood tests and imaging.
- Cervical cancer: Bleeding after sex, between periods or after menopause, persistent discharge or pelvic pain should be evaluated. HPV vaccination and appropriate screening reduce risk.
- Endometrial cancer: Bleeding after menopause is the most common warning sign. It does not always mean cancer, but every episode needs assessment.
- Ovarian and fallopian tube cancers: New, persistent bloating, early fullness, abdominal or pelvic discomfort and urinary symptoms may need evaluation, especially when they occur frequently.
- Prostate cancer: Early disease often causes no symptoms. Urinary symptoms are commonly caused by noncancerous conditions, and the decision to test with PSA should follow an informed discussion of benefits and limitations.
- Kidney and bladder cancers: Blood in the urine needs assessment even when painless or seen only once. Imaging, urine tests and cystoscopy may be used to identify the cause.
- Testicular and penile cancers: A painless testicular lump, change in size or heaviness needs prompt assessment. A persistent penile sore, lump or skin change should also be examined.
- Leukemia: Abnormal blood-forming cells can cause fatigue, infections, fever, bruising, bleeding or bone pain. Diagnosis may require blood tests, bone marrow examination, flow cytometry and genetic testing.
- Lymphoma: Painless swollen lymph nodes, drenching night sweats, unexplained fever, itching or weight loss may need assessment. A tissue biopsy is often required to identify the lymphoma subtype.
- Multiple myeloma: This plasma-cell cancer may cause bone pain, anemia, kidney problems, recurrent infections or high calcium. Blood, urine, bone marrow and imaging tests help establish the diagnosis.
- Myelodysplastic and myeloproliferative disorders: These conditions affect blood-cell production and may cause low or high blood counts, clotting, bleeding or enlargement of the spleen. Treatment varies widely by subtype and risk.
- Selected noncancerous blood disorders: Hematology care may also include assessment of anemia, low platelets, clotting disorders, hemoglobin disorders and bone marrow failure.
Childhood cancers: Leukemias, lymphomas, brain tumors, neuroblastoma, Wilms tumor, bone tumors and soft-tissue sarcomas are among the cancers seen in younger patients. Persistent unexplained fever, pallor, bruising, swelling, bone pain, headaches or changes in balance or vision should be evaluated. These symptoms often have noncancerous causes.
- Brain and spinal tumors: Symptoms vary with location and may include new seizures, persistent or worsening headaches, weakness, sensory changes, balance problems or changes in behavior or vision.
- Bone and soft-tissue sarcomas: A growing lump, persistent deep pain or unexplained swelling requires assessment. Biopsy should be planned by the team that will manage the tumor because the route can affect later surgery.
- Skin cancers: A changing mole, a sore that does not heal or a new skin growth should be examined. Any suspicious lesion may need dermoscopic assessment or biopsy.
- Cancer of unknown primary: Sometimes cancer is found after it has spread but the site where it began is not immediately clear. Pathology, imaging and selected molecular tests help guide further investigation and treatment.
- Cancer surgery
- Chemotherapy
- Targeted therapy
- Immunotherapy
- Hormonal therapy
- External beam radiation therapy
- Stereotactic radiation therapy
- Brachytherapy
- Radiopharmaceutical therapy
- Stem cell transplantation
- Transfusion and hematology support
- Palliative care
- Fertility preservation
- Psycho-oncology and social support
- Rehabilitation
- Nutrition support
- Survivorship and follow-up
Surgery may remove a tumor, assess its extent, relieve an obstruction or other symptom, or support reconstruction. The operation and margin or lymph-node approach differ by cancer type. Minimally invasive, robotic or organ-preserving surgery may be considered for suitable patients.
Medicines that kill or slow rapidly dividing cells may be given by mouth, injection or infusion. Side effects differ by drug and can often be prevented or managed, but urgent review is needed for fever or signs of infection during treatment.
These medicines act on specific proteins or changes that help some cancers grow. Treatment usually requires an appropriate target or clinical indication. Side effects differ from those of chemotherapy but can still be serious and need monitoring.
Immunotherapy helps the immune system recognize or attack certain cancers. Suitability depends on the cancer, approved indication, biomarkers in some cases, previous treatment and overall health. Immune-related side effects can affect almost any organ and should be reported promptly.
Treatment that blocks or lowers hormones may be used for hormone-sensitive breast, prostate, endometrial and other cancers. Side effects and duration depend on the medicine and treatment goal.
Radiation is delivered from a machine outside the body. Planning uses imaging to shape the treatment around the target while limiting exposure to nearby tissues. Treatment may be given in one, a few or many sessions. A person is not radioactive after external beam treatment.
Highly focused radiation may be used for selected small tumors or limited areas of spread in the brain, lung, spine, liver or other locations. Suitability depends on size, location and nearby sensitive structures.
A radiation source is placed inside or close to the treatment area for selected cancers, including some gynecologic and prostate cancers. Temporary or permanent sources and safety precautions vary by procedure.
Radioactive medicines that travel to a specific target may treat selected thyroid, prostate or neuroendocrine cancers. Eligibility, isolation needs and post-treatment precautions depend on the medicine.
High-dose treatment followed by infusion of blood-forming stem cells may be used for selected leukemias, lymphomas, myeloma and marrow disorders. It requires detailed eligibility assessment, donor matching when relevant and close infection monitoring.
Red-cell, platelet or plasma transfusion and treatment of clotting or bleeding problems may be required during cancer care. Blood products are used according to clinical need and testing protocols.
Palliative care focuses on comfort, function and quality of life at any stage of serious illness. It can be provided alongside treatment intended to control or cure cancer and also supports families and caregivers.
Cancer and some treatments can affect fertility. When medically feasible, options such as sperm, egg, embryo or tissue preservation should be discussed before treatment begins. Urgent treatment may limit the time or options available.
Counseling can help patients and families cope with uncertainty, changes in body image, treatment stress, sleep problems, anxiety, low mood and practical concerns.
Physiotherapy, occupational therapy, speech and swallowing therapy, lymphedema care and exercise guidance may help maintain or restore function during and after treatment.
A dietitian can help with reduced appetite, weight loss, swallowing difficulty, altered taste, bowel symptoms and nutrition during treatment. Restrictive diets or supplements should not replace prescribed cancer treatment.
Follow-up may monitor for recurrence, late effects, new health problems and emotional or functional concerns. The schedule and tests depend on the cancer, treatment and time since therapy.
- Molecular profiling
- Modern radiation planning and delivery
- Stereotactic radiosurgery and radiotherapy
- PET-CT and nuclear medicine
- Minimally invasive and robotic surgery
- Interventional oncology
- Infusion and day-care systems
- Stem cell transplant environment
- Digital pathology and multidisciplinary review
Biomarker, genetic and genomic tests can refine diagnosis or help identify treatment options for selected cancers. Results must be interpreted in the clinical context.
Three-dimensional planning, intensity-modulated radiation therapy, image guidance and motion-management techniques can help shape treatment around the target. The technique is selected according to the cancer and treatment goal.
SRS and SBRT can deliver focused treatment in selected cases while limiting the number of sessions. These techniques are not suitable for every tumor.
Molecular imaging can support staging, treatment response assessment and planning for selected cancers. Some tracers can also pair diagnosis with targeted radionuclide treatment.
Laparoscopic, thoracoscopic and robotic platforms may support smaller-incision surgery for suitable tumors. The surgeon recommends the approach that offers the most appropriate cancer control and safety.
Image-guided biopsy, drainage, tumor ablation and embolization may support diagnosis, local treatment or symptom relief in selected patients.
Protocol-based medicine preparation, identity checks, infusion monitoring and emergency response processes support safer systemic treatment.
Transplant care requires controlled rooms, blood-bank support, infection surveillance and an experienced multidisciplinary team.
Digital image sharing and structured case review can help specialists examine pathology, imaging and treatment options together.
A new or growing lump, unexplained bleeding, a persistent cough or hoarseness, a non-healing mouth or skin lesion, a lasting change in bowel or bladder habits, difficulty swallowing, unexplained weight loss or unusual fatigue should be assessed. These symptoms often have noncancerous causes, but persistence or progression matters.
Tumor seeding along a biopsy tract is very rare for most routine biopsies. The care team selects the biopsy method and route according to the suspected tumor because planning is especially important for certain cancers. The diagnostic benefit usually outweighs this small risk when a biopsy is clinically indicated.
Timing varies with the biopsy type, pathology complexity, need for additional stains or molecular tests and the imaging required. The team should explain which results are pending and whether treatment must wait for all of them.
Some cancers can be cured, particularly when found at an earlier stage, while others can be controlled for long periods. Outcomes depend on the cancer type, stage, biology, response to treatment and the person's health. No responsible team can promise a cure before evaluating the individual case.
Cancer is not contagious. Most cancers are not caused by a single inherited change, although some families carry genetic variants that increase risk. Genetic counseling may be helpful when cancer occurs unusually young, affects several relatives or has a pattern linked to an inherited syndrome.
No. Treatment may involve surgery, radiation, hormonal therapy, targeted therapy, immunotherapy, observation or supportive care, with or without chemotherapy. The recommendation depends on the diagnosis and treatment goal.
No. Hair loss depends on the medicine, dose and schedule. Some treatments cause complete hair loss, some cause thinning and others have little effect on hair. Hair usually grows back after treatment, although texture or color can temporarily change.
External beam radiation does not make a person radioactive. Some internal radiation and radiopharmaceutical treatments can require temporary precautions around other people. The nuclear medicine or radiation team provides specific instructions.
Many people work through at least part of treatment, while others need reduced hours or leave. The answer depends on the treatment, symptoms, infection risk, type of work and travel demands. Discuss practical adjustments with the care team and employer.
All cells use glucose for energy. Eliminating sugar has not been shown to cure or control cancer, and highly restrictive diets can cause harmful weight or muscle loss. A balanced diet tailored to symptoms and treatment needs is usually more useful.
Not always. Some can change how cancer medicines work, increase bleeding, affect the liver or kidneys, or contain undeclared ingredients. Tell the oncology team about every supplement or traditional remedy before using it. They should not replace evidence-based treatment.
Yes. A second opinion can confirm the diagnosis, clarify options or help with a major decision. Bring pathology reports and slides or blocks when requested, imaging, laboratory results, treatment records and a current medicine list.
No. Palliative care focuses on pain, symptoms, emotional well-being and quality of life. It can begin at diagnosis and be provided alongside surgery, chemotherapy, radiation or other cancer treatment.
Yes. Some surgery, chemotherapy, radiation and hormonal treatments can reduce fertility temporarily or permanently. When time and medical circumstances allow, fertility preservation should be discussed before treatment begins.
The team creates a follow-up plan based on the cancer and treatment. Visits may address recurrence monitoring, late effects, medicines, vaccination, rehabilitation, emotional health and age-appropriate screening. Report new or persistent symptoms rather than waiting for the next scheduled visit.
Not every cancer is preventable, but risk can be reduced. Avoid tobacco and areca nut, limit or avoid alcohol, stay physically active, maintain a healthy weight, receive recommended HPV and hepatitis B vaccines and take part in appropriate screening. Seek medical advice for persistent symptoms even if a screening test was normal.